Gellycle is a bio-startup established to commercialize a unique hydrogel technology platform invented by Takamasa Sakai, a professor at University of Tokyo, to medical and industrial fields. We develop a new treatment method ”Gel Medicine” by using our hydrogels, which have extremely high biocompatibility and can be physically controlled. Even in the 21st century, there are numerous diseases without cures. Our mission is to respond to these Unmet Medical Needs and improve the QOL of patients around the world; this is our mission with the best Gel Control Technology in the world.